All patients must sign an informed consent indicating that they are aware of the investigational nature of this study; patients must have signed an authorization for the release of their protected health information
Patients must sign an informed consent prior to registration and before undergoing any study-specific procedures indicating that they are aware of the investigational nature of this study
Patients must sign an informed consent indicating that they are aware this is a research study and have been told of its possible benefits and toxic side effects; patients will be given a copy of the consent form
Patient must sign an informed consent document indicating that they are aware of the investigational nature of this study, which includes an authorization for the release of their protected health information
Patients must sign a document that indicates that they are aware of the investigative nature of the treatment of this protocol, and the potential benefits and risks; patients unwilling or unable due to cognitive impairment to sign informed consent are excluded from the study
Patients must have signed an informed consent document stating that they understand the investigational nature of the proposed treatment
Patients must have signed informed consent indicating that they are aware of the investigational nature of the study, and are aware that participation is voluntary; patients must be made aware of their other treatment options
A signed informed consent form approved by the Duke University Institutional Review Board (IRB) will be required for patient enrollment into the study; patients (if 18 years old) or their parent(s) or guardian(s) must be able to read and understand the informed consent document and must sign the informed consent indicating that they are aware of the investigational nature of this study; all children will have to provide assent to the study
All patients must sign an informed consent indicating that they are aware of the investigational nature of this study. Patients must have signed an authorization for the release of their protected health information. Patients must be registered prior to treatment on study.
All patients must be capable to voluntarily sign an informed consent indicating that they are aware of the investigational nature of this study prior to registration
A signed informed consent form approved by the Institutional Review Board (IRB) will be required for patient enrollment into the study; patients must be able to read and understand the informed consent document and must sign the informed consent indicating that they are aware of the investigational nature of this study
Patients must sign an informed consent indicating they are aware of the investigational nature of this study, in keeping with the policies of the hospital
Patients must sign an informed consent form indicating that they are aware of the investigational nature of this study, in keeping with the policies of the hospital
Patients must sign an informed consent and authorization indicating that they are aware of the investigational nature of this study and the known risks involved
Patients must have signed informed consent indicating that they are aware of the investigational nature of the study, and are aware that participation is voluntary
Patients must sign an informed consent document that indicates they are aware of the investigational nature of the treatment in this protocol as well as the potential risks and benefits
Be aware of the nature of her malignancy
Patients must sign an informed consent document that indicates they are aware of the investigational nature of the treatment in this protocol as well as the potential risks and benefits
Patients must be aware of the investigational nature of the therapy and provide written informed consent
All patients must sign an informed consent indicating that they are aware of the investigational nature of this study
Patients must be able to understand and sign an informed consent indicating that they are aware of the investigational nature of this study in keeping with the institutional policies.
Patients must be aware of the investigational nature of the therapy and provide written informed consent
All patients must sign an informed consent approved by the Institutional Review Board indicating that they are aware of the investigational nature of this study; patients must sign an authorization for the release of their protected health information
Patients must voluntarily sign an informed consent indicating that they are aware of the investigational nature of this study in keeping with the policies of the hospital
All patients must sign an informed consent indicating that they are aware of the investigational nature of this study; patients must have signed an authorization for the release of their protected health information at all sites except the National Institutes of Health (NIH)
Ability to understand and the willingness to sign a written informed consent document indicating that they are aware of the investigational nature of the study
Patients must sign informed consent indicating that they are aware of the investigational nature of this study in keeping with the policies of the hospital.
Patients, or legal guardians, and donors must sign an informed consent indicating that they are aware this is a research study and have been told of its possible benefits and toxic side effects
Patients must sign an informed consent document that indicates they are aware of the investigative nature of the treatment in this protocol as well as the potential risks and benefits
Patients must be able to read and understand the informed consent document; patients must sign the informed consent indicating that they are aware of the investigational nature of this study
Patients must sign an informed consent and authorization indicating that they are aware of the investigational nature of this study and the known risks involved
All patients must sign an informed consent indicating that they are aware of the investigational nature of this study
Patients must sign an informed consent prior to registration and before undergoing any study-specific procedures indicating that they are aware of the investigational nature of this study
All patients must be able to provide informed consent indicating that they are aware of the investigational nature of the study; patients must provide an authorization for the release of their protected health information
Patient (or parents/guardians, in the case of minors) must sign an informed consent document indicating that they are aware of the investigational nature of this study, which includes an authorization for the release of their protected health information
All patients must sign a consent form indicating that they are aware of the investigational nature of the study; the informed consent form will indicate that the patient has been made aware of all other appropriate therapies
A signed informed consent form approved by the Duke University Institutional Review Board (IRB) will be required for patient enrollment into the study; patients must be able to read and understand the informed consent document and must sign the informed consent indicating that they are aware of the investigational nature of this study
All patients must sign an informed consent indicating that they are aware of the investigational nature of this study.
All patients must sign an informed consent indicating that they are aware of the investigational nature of this study; patients must be registered prior to treatment with study drug
Patients must sign an informed consent and authorization indicating that they are aware of the investigational nature of this study and the known risks involved
All patients must sign and informed consent approved by the Institutional Review Board indicating that they are aware of the investigational nature of this study; patients must also sign an authorization for the release of their protected heath information
Patients must sign an informed consent form indicating that they are aware of the investigational nature of this study, in keeping with the policies of the hospital
Patients must sign an informed consent indicating they are aware of the investigational nature of this study, in keeping with the policies of the hospital
Patients must sign an informed consent form approved for this purpose by the IRB of the University of Michigan Medical Center indicating that they are aware of the investigational aspects of the treatment and the potential risks
Signed informed consent, which indicates the investigational nature of this study, is required
All patients must sign an informed consent indicating that they are aware of the investigational nature of this study in keeping with the policies of this hospital.
Patients must sign an informed consent indicating that they are aware of the investigational nature of the study
Patients must sign an Informed Consent and Authorization indicating that they are aware of the investigational nature of this study and the known risks involved
Patients must sign an informed consent indicating that they are aware of the investigational nature of this study.
All patients must sign an informed consent indicating that they are aware of the investigational nature of this study; patients must sign an authorization for the release of their protected health information
All patients must sign an informed consent document indicating that they are aware of the investigational nature of this study
All patients must sign an informed consent indicating that they are aware of the investigational nature of this study; patients must sign an authorization for the release of their protected health information
Sign an informed consent indicating they are aware of the investigational nature of this study
Patients unable to give informed consent indicating they are aware of the investigational nature of this intervention prior to entry into the study
SCREENING PHASE: The patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form
INTERVENTION PHASE: The patient is aware of the nature of his/her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form
The patient must be aware of the high risk and experimental nature of the treatment and provide informed consent
The patient is aware of the nature of her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent document
Patients must sign an informed consent form approved for this purpose by the Institutional Review Board (IRB) of the University of Michigan Hospital indicating that they are aware of the investigational nature of this MRI, of the potential but minimal risks of these additional scans, and that their treatments may or may not be altered by the results of these scans
A signed informed consent form approved by the Duke University Institutional Review Board (IRB) will be required for patient enrollment into the study. Patients or their legally authorized representative (LAR) must be able to read and understand the informed consent document and must sign the informed consent indicating that they are aware of the investigational nature of this study. Treating physicians at the time the protocol is presented are able to determine based on their clinical judgment whether patients lack the capacity and require a LAR to sign the consent form
Ability to provide informed consent; all subjects must sign an informed consent form indicating their understanding of the investigational nature and risks of the study before any protocol-related studies are performed
Patients must sign an informed consent indicating that they are aware of the investigational nature of this study, in keeping with the policies of University of Michigan (UM) hospital
Ability to provide informed consent; all subjects must sign an informed consent form indicating their understanding of the investigational nature and risks of the study before any protocol-related studies are performed
Be informed of the investigational nature of this study
The patient is aware of the nature of her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form
Ability of subject to understand and the willingness to sign a written informed consent document indicating that they are aware of the investigational nature of this study, and that this is not a therapeutic clinical trial
